Incorporating information on therapeutic alternatives in prescription drug negotiations IRA | Brookings

Incorporating information on therapeutic alternatives in prescription drug negotiations IRA |  Brookings

The Inflation Reduction Act (IRA) requires the Secretary of Health and Human Services to consider information about therapeutic alternatives to drugs selected for negotiation. The Secretary must have the necessary …

Read more

Chairman Arrington, Health Care Task Force Chair Burgess Lead Letter to CBO on IRA Drug Development Analysis | The United States House Budget Committee – House Budget Committee

Chairman Arrington, Health Care Task Force Chair Burgess Lead Letter to CBO on IRA Drug Development Analysis |  The United States House Budget Committee - House Budget Committee

November 20, 2023 WASHINGTON, DC – House Budget Committee Chairman Jodey Arrington (R-TX) and House Budget Committee Health Care Task Force Chairman Michael C. Burgess, MD (R-TX) led a letter …

Read more